{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T11:33:32Z","timestamp":1767180812196,"version":"build-2238731810"},"reference-count":54,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2010,10,20]],"date-time":"2010-10-20T00:00:00Z","timestamp":1287532800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0013511","type":"journal-article","created":{"date-parts":[[2010,10,20]],"date-time":"2010-10-20T15:01:31Z","timestamp":1287586891000},"page":"e13511","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":31,"title":["A Recombinant Vaccine Effectively Induces C5a-Specific Neutralizing Antibodies and Prevents Arthritis"],"prefix":"10.1371","volume":"5","author":[{"given":"Kutty Selva","family":"Nandakumar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c5sa","family":"Jansson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bingze","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niclas","family":"Rydell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna M.","family":"Blom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rikard","family":"Holmdahl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2010,10,20]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/sj.bjp.0707332","article-title":"Function, structure and therapeutic potential of complement C5a receptors.","volume":"152","author":"PN Monk","year":"2007","journal-title":"Br J Pharmacol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0162-3109(00)80302-1","article-title":"Complement components of the innate immune system in health and disease in the CNS.","volume":"49","author":"P Gasque","year":"2000","journal-title":"Immunopharmacology"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1038\/ni.1655","article-title":"Modulation of the antitumor immune response by complement.","volume":"9","author":"MM Markiewski","year":"2008","journal-title":"Nat Immunol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.immuni.2005.02.006","article-title":"C5a negatively regulates toll-like receptor 4-induced immune responses.","volume":"22","author":"H Hawlisch","year":"2005","journal-title":"Immunity"},{"key":"ref5","first-page":"1058","article-title":"Complement. First of two parts.","volume":"344","author":"MJ Walport","year":"2001","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1002\/art.22492","article-title":"Selective therapeutic control of C5a and the terminal complement complex by anti-C5 single-chain Fv in an experimental model of antigen-induced arthritis in rats.","volume":"56","author":"F Fischetti","year":"2007","journal-title":"Arthritis Rheum"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1034\/j.1600-065X.2001.1800103.x","article-title":"Structure and biology of complement protein C3, a connecting link between innate and acquired immunity.","volume":"180","author":"A Sahu","year":"2001","journal-title":"Immunol Rev"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nm1419","article-title":"Generation of C5a in the absence of C3: a new complement activation pathway.","volume":"12","author":"M Huber-Lang","year":"2006","journal-title":"Nat Med"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1146\/annurev.immunol.23.021704.115835","article-title":"Role of C5a in inflammatory responses.","volume":"23","author":"RF Guo","year":"2005","journal-title":"Annu Rev Immunol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.molimm.2005.06.028","article-title":"Complement and Toll-like receptors: key regulators of adaptive immune responses.","volume":"43","author":"H Hawlisch","year":"2006","journal-title":"Mol Immunol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1172\/JCI26582","article-title":"A regulatory role for the C5a anaphylatoxin in type 2 immunity in asthma.","volume":"116","author":"J Kohl","year":"2006","journal-title":"J Clin Invest"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0161-5890(01)00041-4","article-title":"Anaphylatoxins and infectious and non-infectious inflammatory diseases.","volume":"38","author":"J Kohl","year":"2001","journal-title":"Mol Immunol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"3702","DOI":"10.1182\/blood-2003-03-0703","article-title":"Inhibition of C5a-induced inflammation with preserved C5b-9-mediated bactericidal activity in a human whole blood model of meningococcal sepsis.","volume":"102","author":"T Sprong","year":"2003","journal-title":"Blood"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0065-2776(04)82005-4","article-title":"The role of antibodies in mouse models of rheumatoid arthritis, and relevance to human disease.","volume":"82","author":"PA Monach","year":"2004","journal-title":"Adv Immunol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/ar2089","article-title":"Antibody-induced arthritis: disease mechanisms and genes involved at the effector phase of arthritis.","volume":"8","author":"KS Nandakumar","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1084\/jem.20081862","article-title":"Structure and pathogenicity of antibodies specific for citrullinated collagen type II in experimental arthritis.","volume":"206","author":"H Uysal","year":"2009","journal-title":"J Exp Med"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00441-009-0816-8","article-title":"Pathogenic antibody recognition of cartilage.","volume":"339","author":"KS Nandakumar","year":"2010","journal-title":"Cell Tissue Res"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"4340","DOI":"10.4049\/jimmunol.164.8.4340","article-title":"A role for complement in antibody-mediated inflammation: C5-deficient DBA\/1 mice are resistant to collagen-induced arthritis.","volume":"164","author":"Y Wang","year":"2000","journal-title":"J Immunol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.4049\/jimmunol.176.3.1525","article-title":"Therapeutic vaccination of active arthritis with a glycosylated collagen type II peptide in complex with MHC class II molecules.","volume":"176","author":"B Dzhambazov","year":"2006","journal-title":"J Immunol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1038\/nbt1342","article-title":"Complement-targeted therapeutics.","volume":"25","author":"D Ricklin","year":"2007","journal-title":"Nat Biotechnol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/nrd3011","article-title":"Therapeutic potential of complement modulation.","volume":"9","author":"E Wagner","year":"2009","journal-title":"Nat Rev Drug Discov"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1136\/ard.2007.085753","article-title":"C4b-binding protein (C4BP) inhibits development of experimental arthritis in mice.","volume":"68","author":"AM Blom","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1002\/eji.200424895","article-title":"Complement activation by both classical and alternative pathways is critical for the effector phase of arthritis.","volume":"34","author":"MA Hietala","year":"2004","journal-title":"Eur J Immunol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.4049\/jimmunol.177.3.1904","article-title":"Alternative complement pathway activation is essential for inflammation and joint destruction in the passive transfer model of collagen-induced arthritis.","volume":"177","author":"NK Banda","year":"2006","journal-title":"J Immunol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.1365-2249.2009.04035.x","article-title":"Complement activation pathways in murine immune complex-induced arthritis and in C3a and C5a generation in vitro.","volume":"159","author":"NK Banda","year":"2010","journal-title":"Clin Exp Immunol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"28540","DOI":"10.1074\/jbc.M704354200","article-title":"C4b-binding protein and factor H compensate for the loss of membrane-bound complement inhibitors to protect apoptotic cells against excessive complement attack.","volume":"282","author":"LA Trouw","year":"2007","journal-title":"J Biol Chem"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"32301","DOI":"10.1074\/jbc.M504828200","article-title":"The extracellular matrix and inflammation: fibromodulin activates the classical pathway of complement by directly binding C1q.","volume":"280","author":"A Sjoberg","year":"2005","journal-title":"J Biol Chem"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1084\/jem.157.6.2029","article-title":"Expression of C5a-like biological activities by the fifth component of human complement (C5) upon limited digestion with noncomplement enzymes without release of polypeptide fragments.","volume":"157","author":"RA Wetsel","year":"1983","journal-title":"J Exp Med"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"535","DOI":"10.4049\/jimmunol.104.3.535","article-title":"C5 chemotactic fragments produced by an enzyme in lysosomal granules of neutrophils.","volume":"104","author":"PA Ward","year":"1970","journal-title":"J Immunol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0002-9440(10)64461-6","article-title":"Generation of C5a by phagocytic cells.","volume":"161","author":"M Huber-Lang","year":"2002","journal-title":"Am J Pathol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/349614a0","article-title":"The chemotactic receptor for human C5a anaphylatoxin.","volume":"349","author":"NP Gerard","year":"1991","journal-title":"Nature"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1084\/jem.20020205","article-title":"Essential role for the C5a receptor in regulating the effector phase of synovial infiltration and joint destruction in experimental arthritis.","volume":"196","author":"EP Grant","year":"2002","journal-title":"J Exp Med"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1172\/JCI16577","article-title":"C5a anaphylatoxin is a major regulator of activating versus inhibitory FcgammaRs in immune complex-induced lung disease.","volume":"110","author":"N Shushakova","year":"2002","journal-title":"J Clin Invest"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"33296","DOI":"10.1074\/jbc.M804617200","article-title":"PI3Kgamma and PI3Kdelta: Linkers of coordinate C5aR-FcgammaR activation and immune complex-induced inflammation.","volume":"283","author":"S Konrad","year":"2008","journal-title":"J Biol Chem"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"37906","DOI":"10.1074\/jbc.M707937200","article-title":"Characterization of the murine Fcgamma RIII and Fcgamma RIIB gene promoters: A single two-nucleotide difference determines their inverse responsiveness to C5A.","volume":"282","author":"S Konrad","year":"2007","journal-title":"J Biol Chem"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1096\/fj.02-0209com","article-title":"Protection of innate immunity by C5aR antagonist in septic mice.","volume":"16","author":"MS Huber-Lang","year":"2002","journal-title":"Faseb J"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1002\/art.10449","article-title":"Antiarthritic activity of an orally active C5a receptor antagonist against antigen-induced monarticular arthritis in the rat.","volume":"46","author":"TM Woodruff","year":"2002","journal-title":"Arthritis Rheum"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1096\/fj.05-5814com","article-title":"Therapeutic activity of C5a receptor antagonists in a rat model of neurodegeneration.","volume":"20","author":"TM Woodruff","year":"2006","journal-title":"FASEB J"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1093\/rheumatology\/kem222","article-title":"Blocking the receptor for C5a in patients with rheumatoid arthritis does not reduce synovial inflammation.","volume":"46","author":"CE Vergunst","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"ref40","first-page":"529","article-title":"Drug evaluation: the C5a receptor antagonist PMX-53.","volume":"8","author":"J Kohl","year":"2006","journal-title":"Curr Opin Mol Ther"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nm1753","article-title":"Functional roles for C5a receptors in sepsis.","volume":"14","author":"D Rittirsch","year":"2008","journal-title":"Nat Med"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/j.1365-2796.2003.01303.x","article-title":"HMGB1 is a potent trigger of arthritis.","volume":"255","author":"U Andersson","year":"2004","journal-title":"J Intern Med"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/10512","article-title":"Protective effects of C5a blockade in sepsis.","volume":"5","author":"BJ Czermak","year":"1999","journal-title":"Nat Med"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"7902","DOI":"10.4049\/jimmunol.178.12.7902","article-title":"C5a-blockade improves burn-induced cardiac dysfunction.","volume":"178","author":"LM Hoesel","year":"2007","journal-title":"J Immunol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1074-7613(02)00275-3","article-title":"Arthritis critically dependent on innate immune system players.","volume":"16","author":"H Ji","year":"2002","journal-title":"Immunity"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1038\/nbt1248","article-title":"Human C5aR knock-in mice facilitate the production and assessment of anti-inflammatory monoclonal antibodies.","volume":"24","author":"H Lee","year":"2006","journal-title":"Nat Biotechnol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2174\/0929867053363379","article-title":"Targeting C5a: recent advances in drug discovery.","volume":"12","author":"M Allegretti","year":"2005","journal-title":"Curr Med Chem"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S0161-5890(96)00078-8","article-title":"Inhibition of complement activity by humanized anti-C5 antibody and single-chain Fv.","volume":"33","author":"TC Thomas","year":"1996","journal-title":"Mol Immunol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.it.2008.01.007","article-title":"Therapeutic cleavage of IgG: new avenues for treating inflammation.","volume":"29","author":"KS Nandakumar","year":"2008","journal-title":"Trends Immunol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"3952","DOI":"10.4049\/jimmunol.177.6.3952","article-title":"Backcross and partial advanced intercross analysis of nonobese diabetic gene-mediated effects on collagen-induced arthritis reveals an interactive effect by two major loci.","volume":"177","author":"AK Lindqvist","year":"2006","journal-title":"J Immunol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/art.1780290314","article-title":"Characterization of the antibody response in mice with type II collagen-induced arthritis, using monoclonal anti-type II collagen antibodies.","volume":"29","author":"R Holmdahl","year":"1986","journal-title":"Arthritis Rheum"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1074\/jbc.273.3.1551","article-title":"Arthritis-related B cell epitopes in collagen II are conformation-dependent and sterically privileged in accessible sites of cartilage collagen fibrils.","volume":"273","author":"S Schulte","year":"1998","journal-title":"J Biol Chem"},{"key":"ref53","first-page":"215","article-title":"Genetic analysis of mouse models for rheumatoid arthritis.","author":"R Holmdahl","year":"1998"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/BF00373114","article-title":"High antibody response to autologous type II collagen is restricted to H-2q.","volume":"24","author":"R Holmdahl","year":"1986","journal-title":"Immunogenetics"}],"updated-by":[{"DOI":"10.1371\/annotation\/90e60d13-28ac-4eed-8104-893bead21eb7","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2011,1,22]],"date-time":"2011-01-22T00:00:00Z","timestamp":1295654400000}}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0013511","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,3]],"date-time":"2023-06-03T18:44:54Z","timestamp":1685817894000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0013511"}},"subtitle":[],"editor":[{"given":"Carol","family":"Feghali-Bostwick","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2010,10,20]]},"references-count":54,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2010,10,20]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0013511","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10,20]]}}}